Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: Results of a randomized, controlled trial.
Iconomou G, Koutras A, Rigopoulos A, Vagenakis AG, Kalofonos HP
J Pain Symptom Manage 2003;25(6):512-518.
Review by
The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH
Laryngoscope 2002;112(7):1221-1229.
Review by Henry DH
Recombinant human erythropoietin in pediatric oncology: a review.
Feusner J, Hastings C
Med Pediatr Oncol 2002;39(4):463-468.
Review by Ford PA
Intraoperative low-volume acute normovolemic hemodilution in adult open-heart surgery.
Casati V, Speziali G, D’Alessandro C, et al.
Anesthesiology 2002;97(2):367-373.
Review by Van der Linden P***; Messmer K****
Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic, effect.
Molenaar IQ, Legnani C, Groenland TH, et al.
Liver Transplant 2001;7(10):896-903.
Review by W. Dietrich
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
An excellent study about the use of AT III in septic patients. Carefully conducted study: the description in the method section is outstanding. It is... Read More
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659